Seeking Alpha

Sarepta Therapeutics (SRPT) will update investors on the regulatory progress of eteplirsen...

Sarepta Therapeutics (SRPT) will update investors on the regulatory progress of eteplirsen tomorrow on a conference call scheduled for 8 a.m. EDT. Shares -2% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)